The significance of the P-selectin-PSGL1 connection in the pathophysiology of SLE is demonstrated by the fact that inhibiting the P-selectin-PSGL1 axis with a monoclonal antibody to P-selectin causes a milder form of lupus-like illness [156]. Here, SELP is linked to systemic lupus erythematosus.